These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9468561)

  • 1. Lack of evidence for expression of Fas ligand in Fas-bearing tumors.
    Takagi A; Imai A; Horibe S; Ohno T; Tamaya T
    Oncol Rep; 1998; 5(2):377-80. PubMed ID: 9468561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
    Bi SN; Dai SZ; Yao Q; Che YC; Wang N
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
    Imai A; Ohno T; Ohsuye K; Tamaya T
    Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():550-5. PubMed ID: 7880073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H; Koizumi T; Sugimoto T; Chakraborty S; Ichimura T; Hasegawa K; Nishimura R
    Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors.
    Imai A; Horibe S; Takagi A; Ohno T; Tamaya T
    Eur J Obstet Gynecol Reprod Biol; 1997 Jul; 74(1):73-8. PubMed ID: 9243207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    Int J Oncol; 1998 Jul; 13(1):97-100. PubMed ID: 9625809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas and FasL in human serous ovarian epithelial tumors.
    van Haaften-Day C; Russell P; Davies S; King NJ; Tattersall MH
    Hum Pathol; 2003 Jan; 34(1):74-9. PubMed ID: 12605369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
    Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies.
    Ben-Hur H; Gurevich P; Huszar M; Ben-Arie A; Berman V; Tendler Y; Tchanishev R; Zinder O; Mor G; Zaltsman Y; Kohen F; Zusman I
    Eur J Gynaecol Oncol; 1999; 20(4):249-53. PubMed ID: 10475115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
    Li PL; Liu MM; Ni J
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
    Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z
    Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.
    Chu S; Mamers P; Burger HG; Fuller PJ
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1200-5. PubMed ID: 10720062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.
    Wang M; Wang J; Wang L; Wu L; Xin X
    Med Oncol; 2010 Dec; 27(4):1329-35. PubMed ID: 20012562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
    Negus RP; Stamp GW; Relf MG; Burke F; Malik ST; Bernasconi S; Allavena P; Sozzani S; Mantovani A; Balkwill FR
    J Clin Invest; 1995 May; 95(5):2391-6. PubMed ID: 7738202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the endothelial cell differentiation gene 7 (EDG-7), a lysophosphatidic acid receptor, in ovarian tumor.
    Nakamoto T; Yasuda K; Yasuhara M; Yoshimura T; Kinoshita T; Nakajima T; Okada H; Ikuta A; Kanzaki H
    J Obstet Gynaecol Res; 2005 Aug; 31(4):344-51. PubMed ID: 16018784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.
    Reimer D; Steppan I; Wiedemair A; Concin N; Hofstetter G; Marth C; Müller-Holzner E; Zeimet AG
    Int J Cancer; 2007 Jun; 120(12):2568-75. PubMed ID: 17278108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
    Feng QL; Shi HR; Qiao LJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.